Literature DB >> 20406601

Neurological manifestations of Chagas' disease.

Ezequiel Córdova1, Elena Maiolo, Marcelo Corti, Tomás Orduña.   

Abstract

OBJECTIVES: To review the neurological manifestations of Chagas' disease, including its clinical presentation, diagnosis, management, treatment and follow-up.
METHODS: A systematic review of the literature found in MEDLINE, EMBASE, LILACS and SCIELO was performed to search for relevant references on Chagas' disease and neurological manifestations.
RESULTS: The involvement of the nervous system in Chagas' disease is well established. The acute phase is described as a meningoencephalitis that more frequently affects children under 2 years old and is almost always fatal in those with coexistent myocarditis and cardiac insufficiency. In the chronic phase, it presents as neuritis that results in altered tendon reflexes and sensory impairment, and is reported in up to 10% of the patients. Isolated cases of central nervous system involvement can also include dementia, confusion, chronic encephalopathy and sensitive and motor deficits. Concurrent immunosuppression, such as that related to human immunodeficiency virus and organ transplantation, can result in the reactivation of the Trypanosoma cruzi infection. In these patients meningoencephalitis and brain abscesses may occur with a high mortality rate despite specific treatment. DISCUSSION: Although neurological involvement is infrequent, it has a high mortality and morbidity rate when is not well diagnosed and treated on time.

Entities:  

Mesh:

Year:  2010        PMID: 20406601     DOI: 10.1179/016164110X12644252260637

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  17 in total

Review 1.  Neurologic manifestations of Chagas disease.

Authors:  Marco Oliveira Py
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

2.  Meningoencephalitis Caused by Reactivation of Chagas Disease in Patient Without Known Immunosuppression.

Authors:  Herbert J Fernandes; Luanda O F Barbosa; Tamara S Machado; João Paulo R Campos; Alexandre S Moura
Journal:  Am J Trop Med Hyg       Date:  2016-12-19       Impact factor: 2.345

Review 3.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Prokineticin receptor identified by phage display is an entry receptor for Trypanosoma cruzi into mammalian cells.

Authors:  K G Khusal; R R Tonelli; E C Mattos; C O Soares; B M Di Genova; M A Juliano; U Urias; W Colli; M J M Alves
Journal:  Parasitol Res       Date:  2014-10-17       Impact factor: 2.289

Review 5.  Re. Re.: "Immunothrombotic dysregulation in Chagas disease and COVID19: a comparative study of anticoagulation".

Authors:  Laura Pérez-Campos Mayoral; María Teresa Hernández-Huerta; Eduardo Pérez-Campos Mayoral; Carlos Alberto Matias Cervantes; Eduardo Pérez-Campos
Journal:  Mol Cell Biochem       Date:  2022-07-13       Impact factor: 3.842

6.  Small fiber neuropathy in the chronic phase of Chagas disease: a case report.

Authors:  Maria Nolano; V Provitera; F Manganelli; A Pagano; A Perretti; L Santoro
Journal:  Clin Auton Res       Date:  2013-03-09       Impact factor: 4.435

7.  Trypanosoma cruzi: experimental parasitism in the central nervous system of albino mice.

Authors:  Antonio Morocoima; Grace Socorro; Régulo Avila; Ana Hernández; Solángel Merchán; Diana Ortiz; Gabriela Primavera; José Chique; Leidi Herrera; Servio Urdaneta-Morales
Journal:  Parasitol Res       Date:  2012-08-07       Impact factor: 2.289

8.  A human astrocytoma cell line is highly susceptible to infection with Trypanosoma cruzi.

Authors:  Juan Camilo Vargas-Zambrano; Paola Lasso; Adriana Cuellar; Concepción Judith Puerta; John Mario González
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-04       Impact factor: 2.743

9.  CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.

Authors:  Renata Buccheri; Maria José Kassab; Vera Lucia Teixeira de Freitas; Sheila Cristina Vicente da Silva; Rita C Bezerra; Zarifa Khoury; Maria Aparecida Shikanai-Yasuda; José E Vidal
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

10.  Negativation of Trypanosoma cruzi PCR within Six Months after Treatment of a Child with Nifurtimox.

Authors:  Lauren Pull; Feriel Touafek; Luc Paris; Guillaume Le Loup; Laurent Brutus; Jean-Yves Siriez
Journal:  PLoS Negl Trop Dis       Date:  2015-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.